JP2022520653A5 - - Google Patents

Info

Publication number
JP2022520653A5
JP2022520653A5 JP2021547792A JP2021547792A JP2022520653A5 JP 2022520653 A5 JP2022520653 A5 JP 2022520653A5 JP 2021547792 A JP2021547792 A JP 2021547792A JP 2021547792 A JP2021547792 A JP 2021547792A JP 2022520653 A5 JP2022520653 A5 JP 2022520653A5
Authority
JP
Japan
Prior art keywords
oligonucleotide
nucleotides
strand
sense strand
antisense strand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021547792A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022520653A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/017129 external-priority patent/WO2020167593A1/en
Publication of JP2022520653A publication Critical patent/JP2022520653A/ja
Publication of JP2022520653A5 publication Critical patent/JP2022520653A5/ja
Withdrawn legal-status Critical Current

Links

JP2021547792A 2019-02-12 2020-02-07 Cyp27a1の発現を阻害するための方法及び組成物 Withdrawn JP2022520653A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962804410P 2019-02-12 2019-02-12
US62/804,410 2019-02-12
PCT/US2020/017129 WO2020167593A1 (en) 2019-02-12 2020-02-07 Methods and compositions for inhibiting expression of cyp27a1

Publications (2)

Publication Number Publication Date
JP2022520653A JP2022520653A (ja) 2022-03-31
JP2022520653A5 true JP2022520653A5 (cg-RX-API-DMAC7.html) 2023-04-13

Family

ID=69941447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021547792A Withdrawn JP2022520653A (ja) 2019-02-12 2020-02-07 Cyp27a1の発現を阻害するための方法及び組成物

Country Status (13)

Country Link
US (1) US20220186229A1 (cg-RX-API-DMAC7.html)
EP (1) EP3908661A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022520653A (cg-RX-API-DMAC7.html)
KR (1) KR20210132661A (cg-RX-API-DMAC7.html)
CN (1) CN113692444A (cg-RX-API-DMAC7.html)
AU (1) AU2020221892A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021015651A2 (cg-RX-API-DMAC7.html)
CA (1) CA3128059A1 (cg-RX-API-DMAC7.html)
CL (2) CL2021002120A1 (cg-RX-API-DMAC7.html)
IL (1) IL285367A (cg-RX-API-DMAC7.html)
MX (1) MX2021009754A (cg-RX-API-DMAC7.html)
SG (1) SG11202108532RA (cg-RX-API-DMAC7.html)
WO (1) WO2020167593A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117384902A (zh) * 2022-10-20 2024-01-12 北京福元医药股份有限公司 用于抑制cyp27a1基因表达的双链核糖核酸及其修饰物、缀合物和用途
JP2026520116A (ja) * 2023-05-11 2026-06-22 大睿生物 MASP2遺伝子活性を制御するためのdsRNA分子

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080023768A (ko) 2000-03-30 2008-03-14 화이트헤드 인스티튜트 포 바이오메디칼 리서치 Rna 간섭의 rna 서열 특이적인 매개체
WO2002030952A2 (en) * 2000-10-13 2002-04-18 Genaissance Pharmaceuticals, Inc. Haplotypes of the cyp27a1 gene
CN100523215C (zh) 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
US20050159378A1 (en) 2001-05-18 2005-07-21 Sirna Therapeutics, Inc. RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
WO2003040395A2 (en) 2001-11-07 2003-05-15 Applera Corporation Universal nucleotides for nucleic acid analysis
US20070265220A1 (en) 2004-03-15 2007-11-15 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
WO2007030167A1 (en) 2005-09-02 2007-03-15 Nastech Pharmaceutical Company Inc. Modification of double-stranded ribonucleic acid molecules
WO2010033225A2 (en) 2008-09-22 2010-03-25 Dicerna Pharmaceuticals, Inc. Compositions and methods for the specific inhibition of gene expression by dsrna possessing modifications
WO2010039543A2 (en) 2008-09-23 2010-04-08 Traversa Therapeutics, Inc. Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
KR20110110776A (ko) 2008-12-18 2011-10-07 다이서나 파마수이티컬, 인크. 유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법
WO2010093788A2 (en) 2009-02-11 2010-08-19 Dicerna Pharmaceuticals, Inc. Multiplex dicer substrate rna interference molecules having joining sequences
US8927513B2 (en) 2009-07-07 2015-01-06 Alnylam Pharmaceuticals, Inc. 5′ phosphate mimics
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
AU2012328680A1 (en) 2011-10-25 2014-05-01 Ionis Pharmaceuticals, Inc. Antisense modulation of GCCR expression
EP2928877B1 (en) 2012-12-06 2020-01-22 Merck Sharp & Dohme Corp. Disulfide masked prodrug compositions and methods
CN107109405A (zh) 2014-06-06 2017-08-29 索尔斯蒂斯生物有限公司 具有生物可逆性和非生物可逆性基团的多核苷酸构建体
EP3865576A1 (en) * 2014-12-15 2021-08-18 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids
KR101916583B1 (ko) * 2017-04-20 2018-11-07 가천대학교 산학협력단 칼피르조밉을 유효성분으로 함유하는 담석증의 예방 또는 치료용 약학적 조성물

Similar Documents

Publication Publication Date Title
JP2021500025A5 (cg-RX-API-DMAC7.html)
CN113164509B (zh) 用于抑制17β-HSD 13型(HSD17B13)表达的RNAi试剂、其组合物和使用方法
ES2936863T3 (es) Métodos para tratar infección por hepatitis B
JP2020536587A5 (cg-RX-API-DMAC7.html)
JP2022551269A5 (cg-RX-API-DMAC7.html)
KR20210148264A (ko) 중추신경계에서 유전자 발현을 억제하는 조성물 및 방법
JP2022517742A5 (cg-RX-API-DMAC7.html)
CN110832077B (zh) 用于抑制α-ENaC表达的RNAi剂及使用方法
KR20220069103A (ko) 최소 플루오린 함량을 갖는 작은 간섭 rna의 화학적 변형
KR20260007576A (ko) 변형된 가이드 rna
EP4081639A1 (en) Pharmaceutical combination of a therapeutic oligonucleotide targeting hbv and a tlr7 agonist for treatment of hbv
TW202130809A (zh) 用於抑制β-ENaC表現之RNAi藥劑、其組合物及使用方法
US11634715B2 (en) Methods and compositions for treating bile duct paucity-associated conditions
TW202237189A (zh) 具有增強之肝靶向的s抗原運輸抑制寡核苷酸聚合物之接合物
US20220186229A1 (en) Methods and compositions for inhibiting expression of cyp27a1
EP1437408A1 (en) Novel antisense oligonucleotide derivatives against hepatitis c virus
CN120400138A (zh) 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
HK40106696A (en) Methods for treating hepatitis b infection
TW202517781A (zh) 寡核苷酸結合物之代謝穩定的碳水化合物靶向配體
TW202504618A (zh) 多聚體rnai藥劑結合物之肝臟遞送平台及其使用方法
HK40084771B (en) RNAi AGENTS FOR INHIBITING EXPRESSION OF PNPLA3, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
HK40032229B (en) Methods for treating hepatitis b infection